GANTRISIN Drug Patent Profile
✉ Email this page to a colleague
When do Gantrisin patents expire, and when can generic versions of Gantrisin launch?
Gantrisin is a drug marketed by Roche and is included in five NDAs.
The generic ingredient in GANTRISIN is sulfisoxazole. There are three drug master file entries for this compound. Additional details are available on the sulfisoxazole profile page.
Summary for GANTRISIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 125 |
Patent Applications: | 4,126 |
Formulation / Manufacturing: | see details |
DailyMed Link: | GANTRISIN at DailyMed |
US Patents and Regulatory Information for GANTRISIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche | GANTRISIN | sulfisoxazole diolamine | INJECTABLE;INJECTION | 006917-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roche | GANTRISIN | sulfisoxazole acetyl | SYRUP;ORAL | 009182-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roche | GANTRISIN | sulfisoxazole diolamine | OINTMENT;OPHTHALMIC | 008414-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roche | GANTRISIN | sulfisoxazole diolamine | SOLUTION/DROPS;OPHTHALMIC | 007757-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roche | GANTRISIN PEDIATRIC | sulfisoxazole acetyl | SUSPENSION;ORAL | 009182-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roche | GANTRISIN | sulfisoxazole | TABLET;ORAL | 006525-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |